Literature DB >> 9600961

HCC-2, a human chemokine: gene structure, expression pattern, and biological activity.

A Pardigol1, U Forssmann, H D Zucht, P Loetscher, P Schulz-Knappe, M Baggiolini, W G Forssmann, H J Mägert.   

Abstract

Cloning and sequencing of the upstream region of the gene of the CC chemokine HCC-1 led to the discovery of an adjacent gene coding for a CC chemokine that was named "HCC-2." The two genes are separated by 12-kbp and reside in a head-to-tail orientation on chromosome 17. At variance with the genes for HCC-1 and other human CC chemokines, which have a three-exon-two-intron structure, the HCC-2 gene consists of four exons and three introns. Expression of HCC-2 and HCC-1 as studied by Northern analysis revealed, in addition to the regular, monocistronic mRNAs, a common, bicistronic transcript. In contrast to HCC-1, which is expressed constitutively in numerous human tissues, HCC-2 is expressed only in the gut and the liver. HCC-2 shares significant sequence homology with CKbeta8 and the murine chemokines C10, CCF18/MRP-2, and macrophage inflammatory protein 1gamma, which all contain six instead of four conserved cysteines. The two additional cysteines of HCC-2 form a third disulfide bond, which anchors the COOH-terminal domain to the core of the molecule. Highly purified recombinant HCC-2 was tested on neutrophils, eosinophils, monocytes, and lymphocytes and was found to exhibit marked functional similarities to macrophage inflammatory protein 1alpha. It is a potent chemoattractant and inducer of enzyme release in monocytes and a moderately active attractant for eosinophils. Desensitization studies indicate that HCC-2 acts mainly via CC chemokine receptor CCR1.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9600961      PMCID: PMC27666          DOI: 10.1073/pnas.95.11.6308

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

1.  Absence of the type I IFN system in EC cells: transcriptional activator (IRF-1) and repressor (IRF-2) genes are developmentally regulated.

Authors:  H Harada; K Willison; J Sakakibara; M Miyamoto; T Fujita; T Taniguchi
Journal:  Cell       Date:  1990-10-19       Impact factor: 41.582

2.  Mutations that disrupt DNA binding and dimer formation in the E47 helix-loop-helix protein map to distinct domains.

Authors:  A Voronova; D Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

3.  Positive and negative regulation of transcription in vitro: enhancer-binding protein AP-2 is inhibited by SV40 T antigen.

Authors:  P J Mitchell; C Wang; R Tjian
Journal:  Cell       Date:  1987-09-11       Impact factor: 41.582

Review 4.  Splicing of messenger RNA precursors.

Authors:  R A Padgett; P J Grabowski; M M Konarska; S Seiler; P A Sharp
Journal:  Annu Rev Biochem       Date:  1986       Impact factor: 23.643

5.  Bifunctional messenger RNAs in eukaryotes.

Authors:  M Kozak
Journal:  Cell       Date:  1986-11-21       Impact factor: 41.582

6.  Analysis of the human guanylin gene and the processing and cellular localization of the peptide.

Authors:  O Hill; M Kuhn; H D Zucht; Y Cetin; H Kulaksiz; K Adermann; G Klock; G Rechkemmer; W G Forssmann; H J Mägert
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-14       Impact factor: 11.205

7.  Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc.

Authors:  E M Blackwood; R N Eisenman
Journal:  Science       Date:  1991-03-08       Impact factor: 47.728

8.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

9.  Ion channels in human neutrophils activated by a rise in free cytosolic calcium concentration.

Authors:  V von Tscharner; B Prod'hom; M Baggiolini; H Reuter
Journal:  Nature       Date:  1986 Nov 27-Dec 3       Impact factor: 49.962

10.  A novel neutrophil-activating factor produced by human mononuclear phagocytes.

Authors:  P Peveri; A Walz; B Dewald; M Baggiolini
Journal:  J Exp Med       Date:  1988-05-01       Impact factor: 14.307

View more
  29 in total

1.  Evidence of CXC, CC and C chemokine production by lymphatic endothelial cells.

Authors:  Sabrina Mancardi; Elena Vecile; Nelson Dusetti; Ezequiel Calvo; Giorgio Stanta; Oscar R Burrone; Aldo Dobrina
Journal:  Immunology       Date:  2003-04       Impact factor: 7.397

2.  Multiple CC chemokines in channel catfish and blue catfish as revealed by analysis of expressed sequence tags.

Authors:  Chongbo He; Eric Peatman; Puttharat Baoprasertkul; Huseyin Kucuktas; Zhanjiang Liu
Journal:  Immunogenetics       Date:  2004-08-07       Impact factor: 2.846

3.  Transcription-mediated gene fusion in the human genome.

Authors:  Pinchas Akiva; Amir Toporik; Sarit Edelheit; Yifat Peretz; Alex Diber; Ronen Shemesh; Amit Novik; Rotem Sorek
Journal:  Genome Res       Date:  2005-12-12       Impact factor: 9.043

Review 4.  The chemokine network. I. How the genomic organization of chemokines contains clues for deciphering their functional complexity.

Authors:  R Colobran; R Pujol-Borrell; M P Armengol; M Juan
Journal:  Clin Exp Immunol       Date:  2007-05       Impact factor: 4.330

5.  Leukotactin-1/CCL15 induces cell migration and differentiation of human eosinophilic leukemia EoL-1 cells through PKCdelta activation.

Authors:  Ji-Sook Lee; In Sik Kim
Journal:  Mol Biol Rep       Date:  2009-08-11       Impact factor: 2.316

6.  Chemokine and chemokine receptor expression in paired peripheral blood mononuclear cells and synovial tissue of patients with rheumatoid arthritis, osteoarthritis, and reactive arthritis.

Authors:  J J Haringman; T J M Smeets; P Reinders-Blankert; P P Tak
Journal:  Ann Rheum Dis       Date:  2005-08-17       Impact factor: 19.103

7.  Circulating levels of immune and inflammatory markers and long versus short survival in early-stage lung cancer.

Authors:  C Bodelon; M Y Polley; T J Kemp; A C Pesatori; L M McShane; N E Caporaso; A Hildesheim; L A Pinto; M T Landi
Journal:  Ann Oncol       Date:  2013-05-16       Impact factor: 32.976

8.  CC chemokine receptor-1 activates intimal smooth muscle-like cells in graft arterial disease.

Authors:  Koichi Shimizu; Manabu Minami; Rica Shubiki; Marco Lopez-Ilasaca; Lindsey MacFarlane; Yukiko Asami; Yuxin Li; Richard N Mitchell; Peter Libby
Journal:  Circulation       Date:  2009-10-19       Impact factor: 29.690

9.  Protein levels of CC chemokine ligand (CCL)15, CCL16 and macrophage stimulating protein in patients with sarcoidosis.

Authors:  A Arakelyan; E Kriegova; Z Kubistova; F Mrazek; M Kverka; R M du Bois; V Kolek; M Petrek
Journal:  Clin Exp Immunol       Date:  2009-03       Impact factor: 4.330

10.  CCL genes in multiple sclerosis and systemic lupus erythematosus.

Authors:  Tamara Vyshkina; Andrew Sylvester; Saud Sadiq; Eduardo Bonilla; Andras Perl; Bernadette Kalman
Journal:  J Neuroimmunol       Date:  2008-07-03       Impact factor: 3.478

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.